Trial intelligence / Profile preview

Randomized placebo-controlled clinical trial of ivermectin in hospitalized patients with COVID-19

2021-002024-21Phase 3Completed

Sponsor
St. Anne's University Hospital Brno
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing Ivermectin + standard of care with Placebo + standard of care (2 arms). Primary endpoint: Primary safety endpoint. Started Apr 2021; status: completed.

02

Drugs

ivermectin
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on 2021-002024-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-002024-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call